Medicine and Dentistry
Cervical Cancer
100%
Gynecological Oncology
90%
Meta-Analysis
57%
Ovarian Cancer
55%
Premature Labor
52%
Polycystic Ovary Syndrome
42%
Neoplasm
36%
Uterine Cancer
35%
Disease
34%
Female Genital Tract Cancer
32%
Malignant Neoplasm
30%
Body Mass Index
29%
Wart Virus
29%
Magnetic Resonance Imaging
29%
Gynecology
29%
Pre-Eclampsia
28%
Oxidative Stress
27%
Odds Ratio
25%
Computer Assisted Tomography
23%
Pregnancy
22%
Prevalence
22%
Obesity
21%
Uterine Myomectomy
21%
Progeny
20%
Lymph Node Metastasis
20%
Messenger RNA
20%
Overall Survival
19%
Promoter Region
18%
Endometriosis
18%
Antioxidant
18%
Recurrent Disease
18%
Breast Cancer
18%
Krukenberg Tumor
17%
Hysterectomy
17%
Observational Study
17%
Radical Hysterectomy
17%
Insulin Resistance
17%
Birth Weight
16%
Cervical Intraepithelial Neoplasia
16%
Pelvis
16%
Endometrium
15%
Positron Emission Tomography
15%
Adverse Event
15%
Cancer Cell
14%
Bisphenol A
14%
Da Vinci Surgical System
13%
Uterine Fibroid
13%
Prospective Cohort Study
13%
Chemoradiotherapy
13%
Cross Sectional Study
13%
Retroperitoneal Lymph Node Dissection
13%
Placenta
12%
Metabolic Syndrome
12%
Diagnostic Performance
12%
Dose Response
12%
Genetic Polymorphism
12%
Metastatic Carcinoma
11%
Cytokine
11%
Logistic Regression Analysis
11%
Surgery
11%
Low Birth Weight
11%
Adjuvant Therapy
11%
Cohort Analysis
11%
Subgroup Analysis
11%
Surgical Technique
10%
Cardiovascular Disease
10%
Incision
10%
Biological Marker
10%
Survival Rate
10%
Triacylglycerol
10%
Fertility Preservation
10%
Cervical Cancer Screening
10%
Radical Surgery
10%
Minimally Invasive Procedure
10%
Haplotype
10%
Cisplatin
10%
Myoma
10%
Radiation Therapy
10%
Socioeconomic Status
10%
Endometrial Hyperplasia
10%
Wart Virus Vaccine
9%
Uterine Artery Embolization
9%
Therapy Effect
9%
Second Trimester Pregnancy
9%
DNA Methylation
9%
Case-Control Study
9%
Dietary Intake
9%
Disease Free Survival
9%
Ascorbic Acid
9%
Methylation
9%
Diagnosis
9%
Phthalic Acid
9%
Neoadjuvant Chemotherapy
9%
Clinical Guideline
9%
Diet Restriction
9%
Middle Age
9%
Cervix
9%
Hormone Therapy
8%
Levonorgestrel
8%
Operation Duration
8%
Biochemistry, Genetics and Molecular Biology
Gene Polymorphism
43%
Promoter Region
37%
Genetic Polymorphism
35%
Cancer Cell
33%
Birth Weight
32%
Genotyping
31%
Methylation
30%
Blood Level
26%
Pregnancy
25%
Single-Nucleotide Polymorphism
25%
Metabolite
23%
Prospective Cohort Study
23%
Messenger RNA
23%
Progeny
22%
Term Birth
21%
Cohort Study
20%
DNA Methylation
20%
Body Mass
20%
Allele
19%
Oxidative Stress
18%
Haplotype
18%
Prevalence
17%
Prospective Study
16%
Single Nucleotide Polymorphism
15%
Glutathione S-Transferase
14%
Receptor Gene
13%
Liquid
13%
Methylenetetrahydrofolate Reductase
13%
Metabolic Pathway
13%
Lectin
13%
Second Trimester Pregnancy
13%
Case-Control Study
12%
Cancer Screening
12%
Blood Plasma
12%
Genetic Divergence
12%
Aneuploidy
12%
Aryldialkylphosphatase
11%
BRCA1
11%
Paraoxonase
11%
Pharmacokinetics
11%
Insulin Resistance
11%
Wild Type
11%
Homozygote
11%
GSTT1
10%
Vascular Endothelial Growth Factor
10%
Adrenergic Receptor
10%
Triglyceride
10%
Cross Sectional Study
10%
Mass Spectrometry
10%
Polymerase Chain Reaction
10%
Genome-Wide Association Study
10%
First Trimester Pregnancy
9%
Postnatal Growth
9%
CD34
9%
Passive Smoking
9%
Bone Density
9%
Observational Study
9%
Glucose Metabolism
9%
Low-Density Lipoprotein
9%
Wart Virus
9%
LDL Receptor
9%
Trophoblast
9%
Gene Expression
9%
Epigenetics
8%
Carcinogenesis
8%
Homocysteine
8%
Vitamin C
8%
Vitamin E
8%
Lysophosphatidylcholine
8%
Blood Pressure
8%
Angiotensin-Converting Enzyme
7%
Tyrosine Phosphorylation
7%
Sphingosine-1-Phosphate
7%
Triacylglycerol Level
7%
Catenin
7%
Cisplatin
7%
Amnion Fluid
7%
Ataxia Telangiectasia Mutated
7%
Cadherin
7%
Nitric Oxide Synthase
7%
Exon
7%
Low Birth Weight
7%
Fetus Growth
7%
Cytosine
7%
CpG Site
7%
Gene Linkage Disequilibrium
6%
Prenatal Growth
6%
Third Trimester Pregnancy
6%
Microflora
6%
Body Weight
6%
Proteomics
6%
Waist Circumference
6%
Oxidoreductase
6%
Uric Acid Blood Level
5%
Fat Mass
5%
Vitamin D
5%
Interstitial Collagenase
5%
Superoxide Dismutase
5%
Autoantibodies
5%
Fucosylation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Premature Labor
99%
Uterine Cervix Cancer
61%
Malignant Neoplasm
41%
Obesity
28%
Ritodrine
27%
Low Birth Weight
27%
Ovary Cancer
27%
Adverse Event
25%
Cohort Study
25%
Prevalence
23%
Disease
21%
Neoplasm
20%
Ovary Polycystic Disease
18%
Messenger RNA
17%
Adverse Drug Reaction
17%
Observational Study
17%
4,4' Isopropylidenediphenol
15%
Human Papillomavirus
15%
Recurrent Disease
14%
Anti-Inflammatory Drug
14%
Prospective Study
14%
Cisplatin
14%
Case-Control Study
13%
Biological Marker
13%
Insulin Resistance
12%
Endometriosis
12%
Prospective Cohort Study
11%
Antioxidant
11%
Triacylglycerol
11%
Overall Survival
10%
Cardiovascular Disease
10%
Cytokine
10%
Pregnancy Diabetes Mellitus
10%
Breast Cancer
10%
Replacement Therapy
9%
Glutathione Transferase M1
9%
Homocysteine
9%
Maternal Exposure
9%
Ovary Carcinoma
9%
Small for Date Infant
9%
Androgen
9%
Wart Virus Vaccine
8%
Paclitaxel
8%
Placebo
8%
Small Interfering RNA
8%
Carboxylate
8%
Endometrium Cancer
8%
Cotinine
8%
Inflammation
8%
Human Papillomavirus Type 16
7%
Adrenergic Receptor
7%
Uvomorulin
7%
Catenin
7%
Sphingosine 1 Phosphate
7%
Pharmacokinetics
7%
Therapeutic Effect
7%
Prenatal Exposure
7%
Disease Free Survival
7%
Large for Gestational Age
7%
Lipopolysaccharide
7%
Uterine Cervix Carcinoma in Situ
6%
Hyperandrogenism
6%
Macrosomia
6%
High Density Lipoprotein Cholesterol
6%
Cross-Sectional Study
6%
Female Genital Tract Cancer
6%
Lactobacillus
6%
Calcium Ion
6%
Glutathione
6%
Tumor Necrosis
6%
Congenital Malformation
6%
Progesterone
6%
Actaea racemosa
5%
Lactobacillus crispatus
5%
Early Menopause
5%
Endometrium Carcinoma
5%
Genetic Risk
5%
Nonalcoholic Fatty Liver
5%
Dienogest
5%
Proopiomelanocortin
5%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
5%
Interleukin 1
5%
Transferase
5%
Mouse Model
5%
Nuclear Factor
5%
Janus Kinase 1
5%
Vasculotropin
5%
Diethylstilbestrol
5%
Sulindac Sulfide
5%
Random Effects Model
5%
Prostaglandin E2
5%
Cancer Growth Factor
5%